Results
|
|
6201.
|
|
|
|
6202.
|
|
|
|
6203.
|
Role of androgen deprivation treatment in patients with castration-resistant prostate cancer, receiving docetaxel-based chemotherapy. [electronic resource] by
- Lee, Jae-Lyun
- Eun Kim, Jeong
- Ahn, Jin-Hee
- Lee, Dae-Ho
- Lee, Junghsin
- Kim, Choung-Soo
- Hyuk Hong, Jun
- Hong, Bumsik
- Song, Cheryn
- Ahn, Hanjong
Producer: 20110602
In:
American journal of clinical oncology vol. 34
Availability: No items available.
|
|
|
6204.
|
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer. [electronic resource] by
- Irshad, S
- Gillett, C
- Pinder, S E
- A'hern, R P
- Dowsett, M
- Ellis, I O
- Bartlett, J M S
- Bliss, J M
- Hanby, A
- Johnston, S
- Barrett-Lee, P
- Ellis, P
- Tutt, A
Producer: 20141203
In:
Breast cancer research and treatment vol. 144
Availability: No items available.
|
|
|
6205.
|
Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy. [electronic resource] by
- Thalgott, M
- Heck, M M
- Eiber, M
- Souvatzoglou, M
- Hatzichristodoulou, G
- Kehl, V
- Krause, B J
- Rack, B
- Retz, M
- Gschwend, J E
- Andergassen, U
- Nawroth, R
Producer: 20150826
In:
Journal of cancer research and clinical oncology vol. 141
Availability: No items available.
|
|
|
6206.
|
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study. [electronic resource] by
- Ricevuto, Enrico
- Cocciolone, Valentina
- Mancini, Maria
- Cannita, Katia
- Romano, Silvio
- Bruera, Gemma
- Pelliccione, Michela
- Adinolfi, Maria Ilaria
- Ciccozzi, Antonietta
- Bafile, Alberto
- Penco, Maria
- Ficorella, Corrado
Producer: 20151204
In:
The oncologist vol. 20
Availability: No items available.
|
|
|
6207.
|
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model. [electronic resource] by
- Qu, Sifeng
- Wang, Kendric
- Xue, Hui
- Wang, Yuwei
- Wu, Rebecca
- Liu, Chengfei
- Gao, Allen C
- Gout, Peter W
- Collins, Colin C
- Wang, Yuzhuo
Producer: 20141015
In:
Molecular oncology vol. 8
Availability: No items available.
|
|
|
6208.
|
|
|
|
6209.
|
|
|
|
6210.
|
|
|
|
6211.
|
|
|
|
6212.
|
Abiraterone acetate and prednisolone for metastatic castration-resistant prostate cancer failing androgen deprivation and docetaxel-based chemotherapy: a phase II bridging study in Korean and Taiwanese patients. [electronic resource] by
- Kwak, Cheol
- Wu, Tony Tong Lin
- Lee, Hyun Moo
- Wu, Hsi Chin
- Hong, Sung Joon
- Ou, Yen Chuan
- Byun, Seok Soo
- Rhim, Hyou Young
- Kheoh, Thian
- Wan, Ying
- Yeh, Howard
- Yu, Margaret K
- Kim, Choung Soo
Producer: 20150825
In:
International journal of urology : official journal of the Japanese Urological Association vol. 21
Availability: No items available.
|
|
|
6213.
|
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial. [electronic resource] by
- Pokrzywinski, Robin
- Secord, Angeles Alvarez
- Havrilesky, Laura J
- Puls, Larry E
- Holloway, Robert W
- Lewandowski, George S
- Higgins, Robert V
- Nycum, Lawrence R
- Kohler, Matthew F
- Revicki, Dennis A
Producer: 20111230
In:
Gynecologic oncology vol. 123
Availability: No items available.
|
|
|
6214.
|
Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. [electronic resource] by
- Armstrong, Andrew J
- Saad, Fred
- Phung, De
- Dmuchowski, Carl
- Shore, Neal D
- Fizazi, Karim
- Hirmand, Mohammad
- Forer, David
- Scher, Howard I
- Bono, Johann De
Producer: 20170828
In:
Cancer vol. 123
Availability: No items available.
|
|
|
6215.
|
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial. [electronic resource] by
- Peters, Solange
- Stahel, Rolf A
- Dafni, Urania
- Ponce Aix, Santiago
- Massutí, Bartomeu
- Gautschi, Oliver
- Coate, Linda
- López Martín, Ana
- van Heemst, Robbert
- Berghmans, Thierry
- Meldgaard, Peter
- Cobo Dols, Manuel
- Garde Noguera, Javier
- Curioni-Fontecedro, Alessandra
- Rauch, Daniel
- Mark, Michael T
- Cuffe, Sinead
- Biesma, Bonne
- van Henten, Arjen M J
- Juan Vidal, Óscar
- Palmero Sanchez, Ramón
- Villa Guzmán, José Carlos
- Collado Martin, Ricardo
- Peralta, Sergio
- Insa, Amelia
- Summers, Yvonne
- Láng, István
- Horgan, Anne
- Ciardiello, Fortunato
- de Hosson, Sander
- Pieterman, Remge
- Groen, Harry J M
- van den Berg, Paul M
- Zielinski, Christoph C
- Chittazhathu Kurian Kuruvilla, Yojena
- Gasca-Ruchti, Adriana
- Kassapian, Marie
- Novello, Silvia
- Torri, Valter
- Tsourti, Zoi
- Gregorc, Vanesa
- Smit, Egbert F
Producer: 20171116
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 12
Availability: No items available.
|
|
|
6216.
|
|
|
|
6217.
|
|
|
|
6218.
|
|
|
|
6219.
|
|
|
|
6220.
|
|